Last kr228.10 DKK
Change Today +0.30 / 0.13%
Volume 206.6K
As of 11:01 AM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

chr hansen holding a/s (CHR) Snapshot

Open
kr226.80
Previous Close
kr227.80
Day High
kr228.70
Day Low
kr226.80
52 Week High
04/24/14 - kr245.40
52 Week Low
10/16/13 - kr185.07
Market Cap
30.7B
Average Volume 10 Days
271.7K
EPS TTM
kr1.09
Shares Outstanding
134.5M
EX-Date
11/27/13
P/E TM
28.1x
Dividend
kr3.13
Dividend Yield
2.74%
Current Stock Chart for CHR HANSEN HOLDING A/S (CHR)

Related News

No related news articles were found.

chr hansen holding a/s (CHR) Related Businessweek News

No Related Businessweek News Found

chr hansen holding a/s (CHR) Details

Chr. Hansen Holding A/S, a bioscience company, develops, produces, and sells natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries. The company’s Cultures and Enzymes division produces cultures, enzymes, and probiotic products that determine the taste, flavor, color, texture, safety, preservation, nutritional value, and health benefits of various consumer products in the food and dairy industries. Its Health and Nutrition division provides probiotic cultures for the dietary supplement, over-the-counter pharmaceutical, infant formula, and animal feed industries. Its Natural Colors division offers natural color solutions for the food and beverage industries, primarily the beverage, confectionery, ice cream, dairy, and fruit preparation segments. The company has strategic alliance with FMC Corporation for development and commercialization of biological crop protection products. Chr. Hansen Holding A/S operates in Europe, the Middle East, Africa, North and South America, and the Asia Pacific. Chr. Hansen Holding A/S was founded in 1874 and is headquartered in Hørsholm, Denmark.

2,500 Employees
Last Reported Date: 07/2/14
Founded in 1874

chr hansen holding a/s (CHR) Top Compensated Officers

Chief Executive Officer and Member of Executi...
Total Annual Compensation: €250.0K
Chief Financial Officer and Member of Executi...
Total Annual Compensation: €560.0K
Executive Vice President of Cultures & Enzyme...
Total Annual Compensation: €570.0K
Executive Vice President of Natural Colors Di...
Total Annual Compensation: €480.0K
Executive Vice President of Stakeholder Relat...
Total Annual Compensation: €390.0K
Compensation as of Fiscal Year 2013.

chr hansen holding a/s (CHR) Key Developments

Chr. Hansen Holding A/S Presents at Kepler Cheuvreux Autumn Conference 2014, Sep-18-2014

Chr. Hansen Holding A/S Presents at Kepler Cheuvreux Autumn Conference 2014, Sep-18-2014 . Venue: Paris, France. Speakers: Anders Mohr Christensen, Senior Director of Investor Relations.

Chr. Hansen Holding A/S Presents at 3rd Annual Berenberg Specialty Chemicals & Food Ingredients Conference, Sep-29-2014

Chr. Hansen Holding A/S Presents at 3rd Annual Berenberg Specialty Chemicals & Food Ingredients Conference, Sep-29-2014 . Venue: Berenberg Offices, 5th Floor, 60 Threadneedle Street, London EC2R 8HP, United Kingdom. Speakers: Anders Mohr Christensen, Senior Director of Investor Relations.

Chr. Hansen Holding A/S Announces Consolidated Earnings Results for the Third Quarter and Nine Months Ended May 31, 2014; Reaffirms its Earnings guidance for the fiscal year 2014

Chr. Hansen Holding A/S announced consolidated earnings results for the third quarter and nine months ended May 31, 2014. For the quarter, revenue was EUR 198.1 million against EUR 191.6 million a year ago. Operating profit (EBIT) was EUR 54.3 million against EUR 52.8 million a year ago. Profit before tax was EUR 51.1 million against EUR 48.5 million a year ago. Profit for the period attributable to shareholders of the company was EUR 37.4 million against EUR 34.9 million a year ago. Basic and diluted earnings per share from continuing operations were EUR 0.28 against EUR 0.26 a year ago. Free cash flow EUR 41 million, compared to EUR 46 million last year. EBITDA was EUR 67.8 million against EUR 65.2 million a year ago. EBIT before special items was EUR 55.0 million against EUR 52.8 million a year ago. Cash flow from operating activities was EUR 54.7 million against EUR 62.3 million a year ago. Net interest-bearing debt was EUR 439 million. For the year to date, revenue was EUR 550.9 million against EUR 544.5 million a year ago. Operating profit (EBIT) was EUR 138.5 million against EUR 133.0 million a year ago. Profit before tax was EUR 128.2 million against EUR 120.9 million a year ago. Profit for the period attributable to shareholders of the company was EUR 93.7 million against EUR 86.9 million a year ago. Basic and diluted earnings per share from continuing operations were EUR 0.70 against EUR 0.66 a year ago. Capital expenditures EUR 41 million, or 7.4% of revenue, compared to EUR 47 million, or 8.6%, in the first nine months of 2012/13. Free cash flow EUR 42 million, compared to EUR 52 million in the first nine months of 2012/13. EBITDA was EUR 181.5 million against EUR 176.9 million a year ago. EBIT before special items was EUR 143.2 million against EUR 133.0 million a year ago. Cash flow from operating activities was EUR 82.3 million against EUR 98.6 million a year ago. The company reaffirmed its earnings guidance for the fiscal year 2014. For the year, organic revenue growth is expected to be between 7 to 9% and EBIT margin before special items is expected to be above 26% and free cash flow before acquisitions and divestments is expected to be around EUR 110 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CHR:DC kr228.10 DKK +0.30

CHR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Balchem Corp $55.24 USD -1.33
Corbion NV €11.91 EUR +0.245
Ebro Foods SA €14.82 EUR -0.195
Koninklijke Wessanen NV €4.69 EUR -0.115
Sensient Technologies Corp $51.13 USD -1.22
View Industry Companies
 

Industry Analysis

CHR

Industry Average

Valuation CHR Industry Range
Price/Earnings 26.3x
Price/Sales 5.1x
Price/Book 5.9x
Price/Cash Flow 26.4x
TEV/Sales 4.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHR HANSEN HOLDING A/S, please visit www.chr-hansen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.